{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:46:34Z","timestamp":1769856394583,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.oftal.2017.03.006","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T22:45:22Z","timestamp":1494888322000},"page":"539-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interfer\u00f3n alfa-2a como tratamiento alternativo para el carcinoma conjuntival de c\u00e9lulas escamosas"],"prefix":"10.1016","volume":"92","author":[{"given":"D.","family":"Cruzado-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Salas-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Tellez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.E.","family":"Alvarez-Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Serpa-Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2017.03.006_bib0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.exer.2014.10.015","article-title":"Pathophysiology of ocular surface squamous neoplasia","volume":"129","author":"Gichuhi","year":"2014","journal-title":"Exp Eye Res."},{"key":"10.1016\/j.oftal.2017.03.006_bib0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.oftal.2012.12.010","article-title":"Carcinoma epidermoide conjuntival: respuesta parad\u00f3jica al colirio interfer\u00f3n","volume":"89","author":"Mata","year":"2014","journal-title":"Arch Soc Esp Oftalmol."},{"key":"10.1016\/j.oftal.2017.03.006_bib0065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bjo.2008.153197","article-title":"Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: A dose comparison study","volume":"94","author":"Galor","year":"2010","journal-title":"Br J Ophthalmol."},{"key":"10.1016\/j.oftal.2017.03.006_bib0070","first-page":"CD005643","article-title":"Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals","author":"Gichuhi","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.oftal.2017.03.006_bib0075","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.ophtha.2004.01.034","article-title":"Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b","volume":"111","author":"Boehm","year":"2004","journal-title":"Ophthalmology."},{"key":"10.1016\/j.oftal.2017.03.006_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/IIO.0b013e3181e246e5","article-title":"Ocular surface squamous neoplasia","volume":"50","author":"Kiire","year":"2010","journal-title":"Int Ophthalmol Clin."},{"key":"10.1016\/j.oftal.2017.03.006_bib0085","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.ophtha.2011.04.001","article-title":"Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection)","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology."},{"key":"10.1016\/j.oftal.2017.03.006_bib0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archopht.1996.01100130253003","article-title":"Conjunctival intraepithelial neoplasia: A possible marker for human immunodeficiency virus infection?","volume":"114","author":"Karp","year":"1996","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.oftal.2017.03.006_bib0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0161-6420(01)00577-2","article-title":"Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon a-2b","volume":"108","author":"Karp","year":"2001","journal-title":"Ophthalmology."},{"key":"10.1016\/j.oftal.2017.03.006_bib0100","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","article-title":"The interferons. Mechanisms of action and clinical applications","volume":"266","author":"Baron","year":"1991","journal-title":"JAMA."}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669117301259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669117301259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T20:59:18Z","timestamp":1535835558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365669117301259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0365669117301259"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2017.03.006","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interfer\u00f3n alfa-2a como tratamiento alternativo para el carcinoma conjuntival de c\u00e9lulas escamosas","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2017.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}